1.
Cancer Cell
; 42(7): 1152-1154, 2024 Jul 08.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38981434
RESUMEN
In this issue of Cancer Cell, Espinosa-Carrasco et al. show that the efficacy of cancer immunotherapies depends upon the formation of intratumoral immune triads between antigen-presenting cells and antigen-specific CD4+ and CD8+ T cells. This interaction reprograms tumor-specific CD8+ T cells to exert potent effector functions and eradicate established solid tumors.